NCT05406635View on ClinicalTrials.gov

Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

February 1, 2026

Study Completion Date

September 1, 2027

Conditions
CardiotoxicityHER2-positive Breast Cancer
Interventions
DIAGNOSTIC_TEST

Biomarkers: Troponins and natriuretic peptides

Biomarker monitored treatment with measurement of NT-proBNP and cTNT / TNI in weeks 0, 9, 18, 30 and 48 of the treatment period.

Trial Locations (4)

5000

RECRUITING

Odense University Hospital, Odense

9000

RECRUITING

Aalborg University Hospital, Aalborg

Unknown

RECRUITING

Rigshospitalet, Copenhagen

NOT_YET_RECRUITING

Herlev University Hospital, Herlev

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

University of Copenhagen

OTHER

lead

Odense University Hospital

OTHER